We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04544293
Brief Title: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (IMPALA-2)

First Submitted : September 3, 2020
First Submitted that Met QC Criteria : September 3, 2020
First Posted : September 10, 2020

Last Update Submitted that Met QC Criteria : December 14, 2022
Last Update Posted : December 15, 2022